Your browser doesn't support javascript.
loading
Impact of Reanalysis of Nitrogen Multiple-Breath Washout on its Relationship with Chest Magnetic Resonance Imaging Findings in Clinically Stable and Pulmonary Exacerbated Children with Cystic Fibrosis.
Meißner, Maria; Steinke, Eva; Wielpütz, Mark Oliver; Joachim, Cornelia; Sommerburg, Olaf; Mall, Marcus Alexander; Stahl, Mirjam.
Afiliação
  • Meißner M; Dept. of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Steinke E; Dept. of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Wielpütz MO; associated partner site, German Center for Lung Research (DZL), Berlin, Germany.
  • Joachim C; Berlin Institute of Health (BIH) at Charité, Berlin Institute of Health (BIH) at Charité, Berlin, Germany.
  • Sommerburg O; Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Mall MA; Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
  • Stahl M; Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany.
Klin Padiatr ; 236(2): 106-115, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38109903
ABSTRACT
RATIONALE Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects lung disease in children with cystic fibrosis (CF). Correction of a cross-talk error in the software of the MBW device Exhalyzer D in a new software version has generated significant interest regarding its impact on previous MBW findings. Since LCI and chest magnetic resonance imaging (MRI) correlated before in CF children, this study aims to reassess previous MBW data after correction. PATIENTS/

METHODS:

Reanalysis of the main findings from a previously published study comparing MBW and MRI in a pediatric CF cohort by reassessment of nitrogen (N2) MBW of 61 stable children with CF, 75 age-matched healthy controls (HC), and 15 CF children with pulmonary exacerbation (PEx) in the corrected software version.

RESULTS:

The corrected LCI (N2LCIcor) decreased in the entire cohort (-17.0 (11.2)%), HC (-8.5 (8.2)%), stable CF children (-22.2 (11.1)%), and within the PEx group at baseline, at PEx and after antibiotic therapy (-21.5 (7.3)%; -22.5 (6.1)%; -21.4 (6.6)%; all P<0.01). N2LCIcor and N2LCIpre correlated with chest MRI scores in stable CF (r=0.70 to 0.84; all P<0.01) without a significant difference between N2LCIcor and N2LCIpre. Change in LCI from baseline to PEx and from PEx to after therapy decreased from N2LCIpre to N2LCIcor, but these changes remained significant (all P=0.001). DISCUSSION/

CONCLUSIONS:

Our results indicate that N2LCIcor is significantly lower than N2LCIpre, but key results published in the original study demonstrating N2MBW and MRI as complementary methods for clinical surveillance in children with CF remain unaffected.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Cística Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Cística Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha